Real-World Effectiveness of Biosimilar Adalimumab in Chronic Inflammatory Diseases of the Skin, Joints and Intestine
16 October 2021
The volume presents real-world experiences with biosimilar adalimumab in the management of chronic inflammatory diseases affecting the skin, joints and intestine. Through clinical cases from dermatology, gastroenterology and rheumatology, it explores treatment effectiveness and safety as well as the clinical implications of switching between biological and biosimilar therapies. The cases focus on chronic plaque psoriasis, Crohn’s disease and psoriatic arthritis, providing a multidisciplinary perspective on the use of biosimilar adalimumab in clinical practice.